Activating Compound | Comment | Organism | Structure |
---|---|---|---|
1,2-dicaproyl-sn-glycero-3-phospho-L-serine | the cofactor activity of factor Va is enhanced in presence of 1,2-dicaproyl-sn-glycero-3-phospho-L-serine. Both C1 and C2 domains of factor Va bind one molecule of 1,2-dicaproyl-sn-glycero-3-phospho-L-serine, with binding to the C1 domain regulating prothrombinase complex assembly | Homo sapiens | |
Factor Va | expression of factor Va with mutations in either the C1 domain, Y1956A/L1957A, the C2 domain, W2063A/W2064A, or both C domains, Y1956A/L1957A/W2063A/W2064A. Mutations in the C1 and C1-C2 domains of recombinant factor Va reduce the rate of activation of prothrombin to thrombin by factor Xa in the presence of 1,2-dicaproyl-sn-glycero-3-phospho-L-serine by 14000- to 15000fold relative to either wild-type or C2 mutant factor Va. The Kd values of factor Xa binding with factor Va wild-type, C2 mutant, C1 mutant, and C1-C2 mutant are 3, 4, 564, and 624 nM, respectively | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
commercial preparation | - |
Homo sapiens | - |